Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Pricing
SKY Learn

Sector: Pharmaceuticals & Biotechnology

Small Cap

Coral Laboratories Share Price

Q: What is the Market Capitalization of Coral Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Coral Laboratories Ltd. is approximately ₹ 132.6 Cr.

Q: What are the PE and PB ratios for Coral Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Coral Laboratories Ltd. is 9.5, and the Price-to-Book (PB) ratio is 0.6.

Q: What is the 52-Week High and Low for Coral Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Coral Laboratories Ltd. shares was ₹ 784.55, and the lowest price was ₹ 360.

Q: What is the current dividend yield for Coral Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Coral Laboratories Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Q: Who are the major shareholders of Coral Laboratories Ltd.?

Significant shareholdings in Coral Laboratories Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Coral Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Coral Laboratories Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

Q: What is the latest dividend information for Coral Laboratories Ltd.?

Coral Laboratories Ltd. last declared a FINAL dividend of ₹ 1.5 per share for the financial period ending 2025. The record date was set as 2025-09-19, and the payment was/is scheduled around 2025-09-19. For the most current dividend announcements, refer to official company filings.

Coral Laboratories Ltd.

₹383

12.45(3.36%)

Trade Now

1st Apr 2026 | 3:10 PM

NSE :

Open Free Demat Account

Coral Laboratories Performance

Price Movement

N/A

₹377.20

₹392.45

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹392.45

Low₹377.20

Open at₹392.45

Prev Close₹370.55

Volumes1.32 K

Avg Price₹385.22

Lower Circuit₹296.45

Upper Circuit₹444.65

Historical Performance

3M High₹496.60

3M Low₹360.00

1 Yr High₹784.55

1 Yr Low₹360.00

3 Yr High₹999.00

3 Yr Low₹225.00

5 Yr High₹999.00

5 Yr Low₹217.00

Coral Laboratories Fundamentals

Market Cap

Below industry Median

132.60 Cr.

PE Ratio (TTM)

Below industry Median

9.50

Dividend Yield

Below industry Median

0.40

Net Profit TTM

48% decr over last year

13.99

Net Profit Growth

48% decr over last year

13.99

PEG Ratio

Negative PEG TTM

-0.20

ROE

35.0% incr over last year

Operating Revenue TTM

87.56

Operating Revenue Growth

24% decr over last year

Book Value

Low in industry

0.60

MFI

MFI is mid-range

RSI

RSI oversold

29.84

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.60

Coral Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	21.56	19.03	18.82	28.13	22.99
Operating Expense	19.67	14.10	16.64	25.45	16.67
Operating Profit	1.89	4.94	2.18	2.68	6.31
Depreciation	0.69	0.45	0.45	0.51	0.50
Interest	0	0.10	0.06	0.04	0.02
Tax	0.92	1.60	1.16	1.02	2.17
Net Profit	2.78	5.82	2.56	2.83	6.14

Coral Laboratories Technicals

Coral Laboratories Ltd. EMA & SMA

₹383.00

20.95 (5.79%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹381

Day EMA10 ₹396.3

Day EMA12 ₹400.6

Day EMA20 ₹412.4

Day EMA26 ₹418

Day EMA50 ₹432

Day EMA100 ₹455.2

Day EMA200 ₹502.2

Coral Laboratories Support and Resistance

Resistance

First Resistance₹390.02

Second Resistance₹409.48

Third Resistance₹421.77

Support

First Support₹358.27

Second Support₹345.98

Third Support₹326.52

Technical Indicators

Day RSI29.84

Day MFI41.00

Day ADX16.08

Day Commodity Channel Index-166.00

William-90.66

Day MACD-17.36

Day MACD Signal Line-10.55

Day ATR24.15

Day ROC125-29.58

Day ROC21-14.16

Coral Laboratories Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	71.5	71.5	71.5	71.5	71.5	71.5
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	28.5	28.5	28.5	28.5	28.5	28.5

Coral Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	5.63 K	6.57 K	85.73%
Week	4.22 K	4.84 K	87.10%
1 Month	2.53 K	3.1 K	81.69%
6 Month	1.33 K	1.67 K	79.94%

Coral Laboratories SWOT Analysis

Strengths16

Weakness14

Opportunity0

Threats0

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Volume Shockers

Coral Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep, 2025	1.5	FINAL	19 Sep, 2025	Equity Share
20 Sep, 2024	2	FINAL		Equity Share
19 Sep, 2019	2	FINAL		Equity Share
18 Sep, 2018	2	FINAL		Equity Share
11 Sep, 2017	5	FINAL		Equity Share
16 Sep, 2016	3	FINAL		Equity Share
08 Sep, 2015	2.5	FINAL		Equity Share
16 Sep, 2014	2	FINAL		Equity Share
18 Sep, 2013	1.5	FINAL		Equity Share
17 Sep, 2012	1.5	FINAL		Equity Share

Coral Laboratories Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.
Price (₹)	₹217	₹36.87	₹5.54	₹99.90	₹345.05	₹105.90
% Change	4.35%	1.99%	4.92%	7.48%	-1.17%	6.10%
Revenue TTM (₹ Cr)	-	₹0.54	₹83.60	-	-	₹282.74
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-34.95	-	-	₹15.30
PE TTM	60.10	-91.90	-1.30	12.30	77.30	25.30
1 Year Return		703.33	428	-27.38		-20.79
ROCE	-	-	-5.63	-	-	-

Similar Stocks

AHCL

Anlon Healthcare Ltd.

₹ 112.54

+1.04%

MEDISTEP

Medistep Healthcare Ltd.

₹ 17.30

+4.85%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 58.01

-5.95%

APL

Asston Pharmaceuticals Ltd.

₹ 78.80

+7.95%

INFLUX

Influx Healthtech Ltd.

₹ 213.20

+5.54%

MEDIORG

Medicamen Organics Ltd.

₹ 22.15

+4.98%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 498.50

+0.98%

ASTONEALAB

Astonea Labs Ltd.

₹ 159.60

+4.25%

AMWILL

Amwill Health Care Ltd.

₹ 30.39

+4.97%

SENORES

Senores Pharmaceuticals Ltd.

₹ 774.50

+1.96%

INNOVACAP

Innova Captab Ltd.

₹ 702.00

+1.76%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 57.40

+11.20%

SHELTER

Shelter Pharma Ltd.

₹ 29.78

+11.00%

TLL

Trident Lifeline Ltd.

₹ 262.75

-2.09%

DPL

Dipna Pharmachem Ltd.

₹ 9.25

+15.34%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.62

+6.64%

FABINO

Fabino Enterprises Ltd.

₹ 15.94

+4.94%

SUPRIYA

Supriya Lifescience Ltd.

₹ 600.00

+6.78%

SIGACHI

Sigachi Industries Ltd.

₹ 19.22

+13.59%

WINDLAS

Windlas Biotech Ltd.

₹ 771.00

+4.65%

VINEETLAB

Vineet Laboratories Ltd.

₹ 29.50

+1.51%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 32.00

+4.92%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 460.50

+8.21%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.44

+10.00%

FAQ's on CORALAB

What is the Market Capitalization of Coral Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Coral Laboratories Ltd. is approximately ₹ 132.6 Cr.

What are the PE and PB ratios for Coral Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Coral Laboratories Ltd. is 9.5, and the Price-to-Book (PB) ratio is 0.6.

What is the 52-Week High and Low for Coral Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Coral Laboratories Ltd. shares was ₹ 784.55, and the lowest price was ₹ 360.

What is the current dividend yield for Coral Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Coral Laboratories Ltd. is 0.4%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Coral Laboratories Ltd.?

Significant shareholdings in Coral Laboratories Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Coral Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Coral Laboratories Ltd. is often compared with other major players such as Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies and Sudeep Pharma for analysis and benchmarking.

What is the latest dividend information for Coral Laboratories Ltd.?

Coral Laboratories Ltd. last declared a FINAL dividend of ₹ 1.5 per share for the financial period ending 2025. The record date was set as 2025-09-19, and the payment was/is scheduled around 2025-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy